For instance, the 2016 heart failure guideline of the European Society of Cardiology recommends close monitoring of creatinine, serum potassium, and urea upon ACE inhibitor therapy initiation, which was not similarly mentioned in the German ramipril SmPC [23]. This evidence concerns the gene ACE and heart failure.